IDA total vs Libya: Cause of death, by non-communicable diseases, ages 0-4, female
IDA total
7.5%
in 2021
Libya
41.6%
in 2021
IDA total rank
37th
Libya rank
37th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- IDA total
- Libya
How they compare
Libya currently reports 41.6% against 7.5% in IDA total, a difference of 34.1%.
That makes Libya's figure about 5.5 times IDA total's.
Across all 6 years both countries report, Libya has been ahead every year.
IDA total ranks 37th and Libya ranks 37th of 47 groups.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA total | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.3% | 28.8% | 24.5% | Libya |
| 2010s | 6.7% | 39.3% | 32.6% | Libya |
| 2020s | 7.5% | 41.5% | 34.0% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, IDA total or Libya?
- Libya, at 41.6% against 7.5% in IDA total as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between IDA total and Libya?
- 34.1%, with Libya ahead.
- How many years of comparable data are there for IDA total and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA total and Libya rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- IDA total ranks 37th and Libya ranks 37th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.